Last Updated on January 13, 2024 by The Health Master
India’s first Biopharma Hub
According to a recent announcement by IT & Industries Minister KT Rama Rao, the state government of Telangana intends to establish India’s first Biopharma Hub (B-Hub), a growth center and biopharma scale-up manufacturing facility.
Hyderabad, which has been the country’s leading biological production centre, is home to several key players such as:
- Dr Reddy’s Laboratories,
- Biological E,
- Bharat Biotech,
- Shantha Biotech,
- Aurobindo,
- Hetero,
- Gland Pharma,
- Virchow Biotech.
Investing in Cell and Gene Therapy
The state government of Telangana is also investing in the cell and gene therapy space, aiming to establish an institute of curative medicine in Hyderabad.
The primary objective of this institute will be to provide affordable development and commercialization of new age curative therapies, particularly cell and gene therapy, for diseases prevalent in India.
This initiative will significantly contribute to the development of the biopharmaceutical industry in the country.
Telangana’s Growing Pharma Industry
Telangana contributes to around 40% of India’s pharma production and is home to more than 1,000 life sciences companies.
With greater development expected in the future, Telangana is the only region in the world to have more than 200 USFDA-approved sites for pharmaceutical manufacturing.
Also read: Hyderabad is having maximum USFDA approved Pharma Units in world
The state government is taking measures to make Telangana a hub for biopharmaceutical manufacturing, which will not only generate employment but also contribute to the overall economic growth of the state and the country.
Conclusion
The development of the Indian biopharmaceutical industry will be significantly aided by Telangana’s plans to create the nation’s first biopharma hub and its investment in cell and gene therapy.
With Hyderabad being a leading biological production centre in the country and Telangana’s contribution to 40% of India’s pharma production, the state is well-positioned to become a hub for biopharmaceutical manufacturing.
This will not only boost the economic growth of the state but also create employment opportunities for its citizens.
Himachal gets first installment of Rs 225 cr for Bulk Drug Park
Pharma gets a boost, Rs 1,250 crore set aside for bulk drug, medical device..
RIICO to develop Medical Devices Park
Bulk drug park: Booster shot for Pharma companies
Medical device park to be developed: Govt will give these 7 exemptions to companies
4 Medical Devices Parks to come up in a total of 1,326 acres
Himachal gets first installment of Rs 225 cr for Bulk Drug Park
Show cause notices issued to 13 Ultrasound Centres
USFDA approves bleeding disorder therapy
Govt firm on Ban of online sale of medicines
‘Chintan Shivir’ to be held with focus on Drug Quality Regulation and Enforcement
Kerala cracks down on violators of Cosmetic Rules
USFDA issues EIR to Strides for Bangalore facility
Drug alert: 67 out of 1348 samples declared as NSQ in January 2023
New DCGI: Rajeev Raghuvanshi appointed head of apex drug regulatory body
Latest Notifications regarding Pharmaceuticals
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon:
